Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·How lingering stress-altered cells affect bone in different contexts
Review or Meta-AnalysisA 2022 review links senescent cells to aging bone in mice, while estrogen loss and tissue repair findings show why human benefits remain unsettled.
-
Evidence date ·How prostate tumors reshape the immune response
Review or Meta-AnalysisA 2021 review traces how immune signals, stromal cells and treatment can alter PD-L1 in prostate cancer, and why combinations remain experimental.
-
Evidence date ·A chitosan fragment study links tumor immune signaling with gemcitabine
Peer-Reviewed PaperA 2022 study links chitosan sugar fragments to lower PD-L1, an immune-suppressing protein, and stronger tumor responses with chemotherapy. Human benefit is unproven.
-
Evidence date ·How immune aging and persistent inflammation may reinforce each other
Review or Meta-AnalysisA 2022 review links senescent cells to persistent inflammation, then explains why IL-6 and intervention findings need biological context.
-
Evidence date ·Sleep loss, Alzheimer’s and what turmeric’s curcumin can show
Review or Meta-AnalysisA 2022 review compares animal findings with a human cognitive study and explains how absorption and brain delivery shape curcumin’s promise.
-
Evidence date ·When aging muscle repair cells falter, their neighborhood matters
Review or Meta-AnalysisA 2022 review links senescent cells to impaired muscle repair, but mouse findings do not establish benefits for human strength or mobility.
-
Evidence date ·Could diet help creatine reach the brain?
Peer-Reviewed PaperA 2021 proposal links dietary Klotho stimulation to CT1, the protein that transports creatine into cells, but brain uptake remains untested.
-
Evidence date ·What plant compounds might do to skin cells that stop dividing
Review or Meta-AnalysisA 2021 review compares skin-cell experiments with a cream study, explaining what each measured and why cosmetic gains do not prove effects on cellular aging.
-
Evidence date ·When prostate cancer defenses meet immune-cell attack
Review or Meta-AnalysisA 2021 review of prostate cancer cell and mouse studies shows why immune treatment may need other approaches—and where patient benefit remains unproven.
-
Evidence date ·How tissue-supporting cells around a tumor could shape treatment
Review or Meta-AnalysisA 2021 review traces how senescent stromal cells alter cancer signals and tissue structure, while patient benefit remains unproven.